CroiValve chosen as a Finalist in the TCT Shark Tank innovation Competition Oct 2020

On Friday October 16th 2020,  Lucy O’Keeffe, CEO CroíValve, participated as one of the finalists in the TCT Shark Innovation Competition presenting “Combined Repair and Replacement Solution for TR” to the distinguished panel of multidisciplinary panel during the Transcatheter Cardiovascular Therapeutics (TCT) Connect conference 2020.

Now in its seventh year, the TCT Shark Tank Innovation Competition was created to highlight the most innovative device concepts and technological developments with the potential to disrupt the cardiovascular field and dramatically change how patients are treated. Six companies were chosen from the extensive number of applicants to present their technology to a distinguished panel of multidisciplinary experts and judged on the following criteria: unmet clinical need, technology differentiation, IP position/viability, biological proof of concept, regulatory pathway, and commercialization potential.

For the third year in a row, the TCT Shark Tank Innovation Competition partnered with the Jon DeHaan Foundation who provided a $200,000 award  to the winner.

“I was a great honour to be chosen as one of the six finalists in this prestigious competition and get the opportunity to showcase our novel technology” said Lucy O’Keeffe, CEO  CroíValve.